Cargando…

CBX4 contributes to radioresistance by regulating autophagic activity in esophageal squamous cell carcinoma

BACKGROUND: The function of Chromobox 4 (CBX4) function has attracted attention in many cancer types due to its unique biological role; however, its mechanism in esophageal squamous cell carcinoma (ESCC) under radiotherapeutic treatment has not yet been investigated. METHODS: Silencing of CBX4 was c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Hongcheng, Chen, Hui, Chen, Guangzong, Liu, Ming, Chu, Li, Gu, Yu, Chen, Yun, Zhang, Chi, Qin, Qin, Chen, Yanan, Chen, Weiwei, Fan, Jianhong, Nie, Yongzhan, Chen, Junqiang, Wu, Shixiu, Sun, Xinchen, Zhao, Weixin, Zhao, Kuaile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577798/ https://www.ncbi.nlm.nih.gov/pubmed/36267739 http://dx.doi.org/10.21037/atm-21-3630

Ejemplares similares

The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Zhang, Xiaofei, et al.
Publicado: (2021)

A Review of Hedgehog Signaling in Radioresistant Esophageal Cancer: Potential Treatment Target
por: Ma, Li, et al.
Publicado: (2023)

Long term results of different radiotherapy techniques and fractions for esophageal squamous cell carcinoma
por: Deng, Jiaying, et al.
Publicado: (2020)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
por: Meng, Jin, et al.
Publicado: (2018)

CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair
por: Zhou, Yuzhen, et al.
Publicado: (2018)

Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma
por: Zhang, Hongfang, et al.
Publicado: (2016)

A nomogram and risk classification model predicts prognosis in Chinese esophageal squamous cell carcinoma patients
por: Deng, Jiaying, et al.
Publicado: (2022)

Identification of critical radioresistance genes in esophageal squamous cell carcinoma by whole-exome sequencing
por: Chen, Zhiming, et al.
Publicado: (2020)

Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer?
por: Li, Xiaoyu, et al.
Publicado: (2021)

FMS-Related Tyrosine Kinase 3 Ligand Promotes Radioresistance in Esophageal Squamous Cell Carcinoma
por: Zhu, Zuoquan, et al.
Publicado: (2021)

A Phase II Study of Apatinib in Patients with Chemotherapy‐Refractory Esophageal Squamous Cell Carcinoma (ESO‐Shanghai 11)
por: Chu, Li, et al.
Publicado: (2021)

Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2018)

Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs
por: Tseng, Ihsuan, et al.
Publicado: (2023)

CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells
por: Xu, Bing, et al.
Publicado: (2021)

RMP promotes the proliferation and radioresistance of esophageal carcinoma
por: Chen, Shaomu, et al.
Publicado: (2019)

FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis
por: Qin, Qin, et al.
Publicado: (2023)

Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy
por: Xu, Bing, et al.
Publicado: (2023)

Single-cell RNA-seq of esophageal squamous cell carcinoma cell line with fractionated irradiation reveals radioresistant gene expression patterns
por: Yang, Ling, et al.
Publicado: (2019)

CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma
por: Zhang, Hongfang, et al.
Publicado: (2017)

Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation
por: Cao, Yuandong, et al.
Publicado: (2021)

CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma
por: Wang, Gang, et al.
Publicado: (2017)

Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
por: Chen, Yun, et al.
Publicado: (2022)

Single Nucleotide Polymorphisms of CBX4 and CBX7 Decrease the Risk of Hepatocellular Carcinoma
por: Tan, Chao, et al.
Publicado: (2019)

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
por: Zhu, Hongcheng, et al.
Publicado: (2015)

Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial
por: Chen, Yun, et al.
Publicado: (2019)

Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma
por: Pan, Fei, et al.
Publicado: (2016)

A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
por: Liu, Qi, et al.
Publicado: (2020)

Identification of a three-gene prognostic signature for radioresistant esophageal squamous cell carcinoma
por: Wang, Xiao-Yan, et al.
Publicado: (2023)

Methylation and expression of PTPN22 in esophageal squamous cell carcinoma
por: Deng, Jiaying, et al.
Publicado: (2016)

Dose escalation based on (18)F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
por: Zhu, Hongcheng, et al.
Publicado: (2022)

A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma
por: Yu, Weiwei, et al.
Publicado: (2017)

Downregulation of H19 decreases the radioresistance in esophageal squamous cell carcinoma cells
por: Luo, Wenguang, et al.
Publicado: (2019)

Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10
por: Chen, Fangyu, et al.
Publicado: (2021)

Endostatin and Oxaliplatin‐Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study
por: Li, Wenxin, et al.
Publicado: (2019)

Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis
por: Liu, Mina, et al.
Publicado: (2014)

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
por: Chen, Yun, et al.
Publicado: (2018)

A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma
por: Zheng, Jianqing, et al.
Publicado: (2022)

Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck
por: Jing, Qiancheng, et al.
Publicado: (2019)

Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing
por: Deng, Jiaying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lkiaj1jjmo2bhanljo62nf3r83